295 related articles for article (PubMed ID: 21906736)
1. Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients.
Santos MJ; Pedro LM; Canhão H; Fernandes E Fernandes J; Canas da Silva J; Fonseca JE; Saldanha C
Atherosclerosis; 2011 Dec; 219(2):821-6. PubMed ID: 21906736
[TBL] [Abstract][Full Text] [Related]
2. Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.
Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2018 Dec; 57(12):2158-2166. PubMed ID: 30102390
[TBL] [Abstract][Full Text] [Related]
3. Hemorheology, ankle brachial pressure index (ABPI) and toe brachial pressure index (TBPI) in metabolic syndrome.
Gyawali P; Richards RS; Tinley P; Nwose EU
Microvasc Res; 2014 Sep; 95():31-6. PubMed ID: 25014911
[TBL] [Abstract][Full Text] [Related]
4. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
Park YJ; Shin YJ; Kim WU; Cho CS
Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
[TBL] [Abstract][Full Text] [Related]
5. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
6. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
[TBL] [Abstract][Full Text] [Related]
7. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Salmon JE; Roman MJ
Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
[TBL] [Abstract][Full Text] [Related]
8. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
[TBL] [Abstract][Full Text] [Related]
9. Rheological alterations and thrombotic events in patients with systemic lupus erythematosus.
Vayá A; Calvo J; Alcalá C; Micó L; Todolí J; Ricart JM
Clin Hemorheol Microcirc; 2012; 51(1):51-8. PubMed ID: 22240368
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
11. Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.
Carbone F; Dallegri F; Montecucco F; Poggi A; Nobili FM; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
Eur J Clin Invest; 2019 May; 49(5):e13089. PubMed ID: 30767212
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
13. Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
Quevedo-Abeledo JC; Rúa-Figueroa Í; Sánchez-Pérez H; Naranjo A; de Armas-Rillo L; Tejera-Segura B; Lopez-Mejías R; González-Gay MÁ; Ferraz-Amaro I
Clin Exp Rheumatol; 2020; 38(5):917-924. PubMed ID: 31969232
[TBL] [Abstract][Full Text] [Related]
14. Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients.
Parra S; Cabré A; Marimon F; Ferré R; Ribalta J; Gonzàlez M; Heras M; Castro A; Masana L
Lupus; 2014 Mar; 23(3):245-54. PubMed ID: 24390652
[TBL] [Abstract][Full Text] [Related]
15. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
[TBL] [Abstract][Full Text] [Related]
16. Haemorheological changes in patients with systemic lupus erythematosus do not seem to be related to thrombotic events.
Vayá A; Murado J; Santaolaria M; Simó M; Micó L; Calvo J; Todolí J; Ricart JM
Clin Hemorheol Microcirc; 2008; 38(1):23-9. PubMed ID: 18094455
[TBL] [Abstract][Full Text] [Related]
17. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
18. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO
Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
Vlachoyiannopoulos PG; Kanellopoulos PG; Ioannidis JP; Tektonidou MG; Mastorakou I; Moutsopoulos HM
Rheumatology (Oxford); 2003 May; 42(5):645-51. PubMed ID: 12709540
[TBL] [Abstract][Full Text] [Related]
20. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
